Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News (Page 3)
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
1 in 3 Children Now Suffer From Chronic Illness
MONDAY, March 17, 2025 – Nearly 1 in 3 children live with a chronic condition that could significantly affect their health for the rest of their lives, a new study says. Chronic illnesses affected...
Turning Off TV Better For Heart Health Of Folks Predisposed To Diabetes
THURSDAY, March 13, 2025 – People with a higher genetic risk for type 2 diabetes also have a higher risk of heart attack, stroke and other heart-related diseases. But controlling that risk could be...
Minimal TV Viewing May Cut ASCVD Risk in Those With T2DM Genetic Risk
WEDNESDAY, March 12, 2025 – Medium and high type 2 diabetes (T2D) genetic risks are not associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD) when television viewing...
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM
MONDAY, March 10, 2025 – For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for developing hematologic cancers...
Continuous Glucose Monitors Overestimate Glycemic Responses
THURSDAY, March 6, 2025 – Continuous glucose monitoring (CGM) can overestimate glycemic responses, according to a study published online Feb. 26 in The American Journal of Clinical Nutrition. Katie...
Recent Decade Saw No Change in Diabetes Prevalence in U.S. Adults
FRIDAY, March 7, 2025 – Between 2013 and 2023, there was no change in the prevalence of diabetes among U.S. adults, but glycemic control worsened, according to a research letter published online...
Makers of Wegovy & Zepbound Cut Prices for Those Without Insurance
FRIDAY, March 7, 2025 – The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance. Novo Nordisk, the ...
GLP-1 Drugs Improve Outlook For Kidney Transplants
THURSDAY, March 6, 2025 – GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study suggests. The drugs help manage patients’ type 2 diabetes and p...
Continuous Glucose Monitors Can Overestimate Blood Sugar Levels, Study Finds
TUESDAY, March 4, 2025 – Continuous blood glucose monitors have been promoted as potentially life-changing for people with diabetes – allowing real-time updates on blood sugar levels without the...
Sotagliflozin Cuts MACE Rate in Patients With T2DM, CKD, CVD Risk Factors
MONDAY, March 3, 2025 – For patients with type 2 diabetes, chronic kidney disease, and additional cardiovascular risk factors, the dual sodium-glucose co-transporter (SGLT)-1/2 inhibitor...
No Suicide Risk Associated With GLP-1 Drugs
FRIDAY, Feb. 28, 2025 – GLP-1 drugs like Ozempic/Wegovy don’t increase a person’s risk of suicidal actions or thoughts, a new study has concluded. Earlier research had potentially linked these drugs ...
Nonarteritic Anterior Ischemic Optic Neuropathy Increased With Semaglutide
WEDNESDAY, Feb. 26, 2025 – For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according...
Depression Risk Lower With GLP-1 Receptor Agonists Versus DPP-4 Inhibitors in Seniors
MONDAY, Feb. 24, 2025 – For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a modestly lower risk for depression compared...
Probability of Cardiovascular Events Lower in Type 1 Diabetes Versus Type 2
TUESDAY, Feb. 25, 2025 – Diabetes mellitus type 1 (DM1) is associated with lower probability of incident cardiovascular events than type 2 (DM2), according to a study published online Feb. 12 in the...
Ozempic, Wegovy Linked To Potential Vision Loss
MONDAY, Feb. 24, 2025 – People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye condition that affects the optic nerve, a new study says....
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Victoza, Mounjaro, Lantus, semaglutide, Trulicity, glipizide, Rybelsus, view more... Farxiga, Jardiance, Lantus Solostar, Humalog, Novolog, liraglutide, Janumet, insulin glargine, tirzepatide, Januvia, insulin lispro, Bydureon, Tresiba, Levemir, dulaglutide, Glucophage, Invokana, insulin degludec, Humulin N